RELEASE (Toronto/ March 11, 2021): A recent survey of Canadian lung cancer patients conducted by Lung Cancer Canada, found considerable confusion about COVID-19 vaccination plans. While 92% of patients indicated that they would receive the vaccine immediately if given, 38% were unsure about when they would receive it, and 24% believed that they would receive it with the general population. Only 37% believed that they
Canada’s drug review and reimbursement systems are already onerous. It can take from two to five years for some drugs to get to patients. The speed with which we have introduced COVID vaccines shows our government can do much better. Protect our Access is advocating for millions of patients across Canada whose lives depend on medical breakthroughs. READ AND SHARE their recent editorial in Ottawa Citizen
55% of Canadian cancer patients, caregivers and those awaiting confirmation of a cancer diagnosis have had appointments, tests, and treatment postponed or cancelled. Half of all Canadians will become cancer patients. We need a plan for their care during the next national crisis because Cancer Can’t Wait. Read our open letter in The Globe and Mail and Le Devoir this World Cancer Day. Read the
Virtual appointments with your doctor including video calls, phone calls, text messages and emails have been the new norm ever since the start of Covid-19. However, this method of contact has a major impact on a patient’s ability to effectively communicate their symptoms and concerns. According to our Leger survey on the Impact of COVID-19 Crisis on Cancer Patients and their Ability to Receive Treatment
Today marks World Cancer Day. Health experts detail the impact of COVID-19 on cancer treatment delays here in Ontario. And a Leger Survey from the Canadian Cancer Survivor Network reflects the impact that these delays in treatment have on patients’ mental health. Click here to access the podcast.
What Good is Targeted Cancer Treatment without the Test? The Canadian Cancer Survivor Network (CCSN) commissioned a review of precision medicine companion diagnostic testing in Canada through a literature review and a series of stakeholder interviews to determine if there were any challenges or barriers that would ultimately impact patient access to companion diagnostics and then issue a series of recommendations to help inform thoughtful